NCT04275180View on ClinicalTrials.gov

Efficacy Argatroban in Ischemic Stroke With Early Deterioration (EASE)

PHASE4CompletedINTERVENTIONAL
Enrollment

628

Participants

Timeline

Start Date

March 21, 2020

Primary Completion Date

July 31, 2022

Study Completion Date

January 31, 2023

Conditions
Acute Progressive Ischemic Stroke
Interventions
DRUG

Argatroban

Argatroban plus standard medical treatment

Trial Locations (6)

310000

Min Lou, Hangzhou

Unknown

People's Hospital of Anji, Anji

Jiaxing Second Hospital, Jiaxing

Ninghai First Hospital, Ninghai

Quzhou Kecheng People's Hospital, Quzhou

Tongxiang Diyi Renmin Hospital, Tongxiang

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT04275180 - Efficacy Argatroban in Ischemic Stroke With Early Deterioration (EASE) | Biotech Hunter | Biotech Hunter